PolyPeptide Group AG (XSWX:PPGN) Inventories, Finished Goods: CHF10.9 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:PPGN PolyPeptide Group AG XSWX:PPGN
76 GF Score
Price CHF43.80
GF Value CHF31.31
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is PolyPeptide Group AG Inventories, Finished Goods?

PolyPeptide Group AG XSWX:PPGN +0.11% 76 Inventories, Finished Goods is CHF10.9 Mil as of Dec. 2025. GuruFocus rates XSWX:PPGN with a GF Score™ of 76/100 and a GF Value™ of CHF31.31 (Significantly Overvalued). The stock has 6 warning signs investors should review.

PolyPeptide Group AG's quarterly finished goods declined from Dec. 2024 (CHF19.6 Mil) to Jun. 2025 (CHF0.0 Mil) but then increased from Jun. 2025 (CHF0.0 Mil) to Dec. 2025 (CHF10.9 Mil).

PolyPeptide Group AG's annual finished goods increased from Dec. 2023 (CHF18.2 Mil) to Dec. 2024 (CHF19.6 Mil) but then declined from Dec. 2024 (CHF19.6 Mil) to Dec. 2025 (CHF10.9 Mil).

PolyPeptide Group AG Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for PolyPeptide Group AG's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PolyPeptide Group AG Inventories, Finished Goods Chart

PolyPeptide Group AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial 23.97 31.80 18.22 19.60 10.87

PolyPeptide Group AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.22 0.00 19.60 0.00 10.87
XSWX:PPGN
76GF Score
PolyPeptide Group AG XSWX:PPGN
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PolyPeptide Group AG Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of CHF10.9 Mil mean?
PolyPeptide Group AG (XSWX:PPGN) has a Inventories, Finished Goods of CHF10.9 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on PolyPeptide Group AG and its competitors.
Is PolyPeptide Group AG's Inventories, Finished Goods too high?
PolyPeptide Group AG's current Inventories, Finished Goods is CHF10.9 Mil. Overall, PolyPeptide Group AG has a GF Score™ of 76/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does PolyPeptide Group AG's Inventories, Finished Goods compare to ZTS and UTHR?
PolyPeptide Group AG's Inventories, Finished Goods of CHF10.9 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Drug Manufacturers company?
A good Inventories, Finished Goods depends on the Drug Manufacturers industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on PolyPeptide Group AG and its competitors. PolyPeptide Group AG's current Inventories, Finished Goods is CHF10.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PolyPeptide Group AG stock overvalued right now?
Based on GuruFocus' analysis, PolyPeptide Group AG (XSWX:PPGN) is currently considered Significantly Overvalued. The stock's GF Value™ is CHF31.31, compared to a current price of CHF43.80 — trading 39.9% above its estimated fair value. The current Inventories, Finished Goods is CHF10.9 Mil. PolyPeptide Group AG's overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For PolyPeptide Group AG (XSWX:PPGN), the current Inventories, Finished Goods is CHF10.9 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PolyPeptide Group AG (XSWX:PPGN) Overvalued in 2026?

Based on GuruFocus' analysis, PolyPeptide Group AG stock appears to be overvalued. The current stock price of CHF43.80 is trading 39.9% above its estimated GF Value™ of CHF31.31. GuruFocus considers PolyPeptide Group AG to be Significantly Overvalued.

Key valuation signals for XSWX:PPGN:

  • Inventories, Finished Goods: CHF10.9 Mil
  • GF Value™: CHF31.31 vs. price of CHF43.80 (39.9% above fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the XSWX:PPGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PolyPeptide Group AG Business Description

Address Neuhofstrasse 24, Baar, Zug, CHE, 6340
PolyPeptide Group AG is an independent contract development and manufacturing organization (CDMO) focused on peptides and oligonucleotides employed as an active pharmaceutical ingredients (APIs) and used as intermediates in therapeutic products. The company derives majority of its revenue from Europe and Asia.
76GF Score

Get the complete analysis for XSWX:PPGN

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF43.80
Price
CHF31.31
GF Value